0001209191-18-004230.txt : 20180118
0001209191-18-004230.hdr.sgml : 20180118
20180118160457
ACCESSION NUMBER: 0001209191-18-004230
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180116
FILED AS OF DATE: 20180118
DATE AS OF CHANGE: 20180118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pellini Michael J
CENTRAL INDEX KEY: 0001402017
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36086
FILM NUMBER: 18534048
MAIL ADDRESS:
STREET 1: 222 DUTTON MILL RD
CITY: WILLISTOWN
STATE: PA
ZIP: 19380
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foundation Medicine, Inc.
CENTRAL INDEX KEY: 0001488613
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 271316416
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 SECOND STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 617-418-2200
MAIL ADDRESS:
STREET 1: 150 SECOND STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-16
0
0001488613
Foundation Medicine, Inc.
FMI
0001402017
Pellini Michael J
150 SECOND STREET
C/O FOUNDATION MEDICINE, INC.
CAMBRIDGE
MA
02141
1
0
0
0
Common Stock
2018-01-16
4
S
0
27138
64.19
D
158844
D
Common Stock
2018-01-17
4
S
0
10150
65.52
D
148694
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.65 to $68.70, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.20 to $66.95, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
/s/ Robert W. Hesslein, as Attorney-in-Fact for Michael J. Pellini
2018-01-18